SCHEMBL14907899

SCHEMBL14907899

Cc1cccc(-c2nnc(SCCC(=O)O)n2C)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.77
TP53 P04637 2/20 0.77
ALDH1A1 P00352 4/20 0.65
LMNA P02545 1/20 0.60
RXFP1 Q9HBX9 1/20 0.58
MAPT P10636 1/20 0.58
THRB P10828 1/20 0.58
KMT2A Q03164 3/20 0.57
POLB P06746 2/20 0.57
MEN1 O00255 2/20 0.57
HDAC3 O15379 1/20 0.57
PTK2 Q05397 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
DRD2 P14416 1/20 0.56
KDM4E B2RXH2 2/20 0.54
RAB9A P51151 1/20 0.54
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907898 0.87 ALDH1A1 (0.75) NPC1TP53ALDH1A1LMNARXFP1
SCHEMBL18556527 0.82 ALDH1A1 (0.68) NPC1TP53ALDH1A1LMNAMAPT
SCHEMBL18540561 0.82 ALDH1A1 (0.75) TP53ALDH1A1LMNARXFP1MAPT
SCHEMBL17213042 0.79 ALDH1A1 (0.70) TP53ALDH1A1LMNARXFP1MAPT
SCHEMBL17068789 0.79 NPC1 (0.75) NPC1TP53ALDH1A1LMNAMAPT
SCHEMBL6408638 0.76 TP53 (0.74) NPC1TP53ALDH1A1LMNARXFP1
SCHEMBL6405166 0.76 MAPT (0.71) TP53ALDH1A1RXFP1MAPTKMT2A
SCHEMBL14907838 0.75 DGAT1 (0.60) ALDH1A1LMNARXFP1KMT2APOLB
SCHEMBL15329746 0.75 ALDH1A1 (0.59) NPC1TP53ALDH1A1RXFP1MAPT
SCHEMBL4203841 0.75 SENP1 (0.74) TP53ALDH1A1LMNARXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 NPC1 4217/4885TP53 3473/4885ALDH1A1 4731/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 NPC1 4217/4885TP53 3473/4885ALDH1A1 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.